Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00013845 · ClinicalTrials.gov registry record

Evaluation and Treatment of Patients With Epilepsy

A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Terminated
Registry status
1,278
Enrollment target

NCT00013845 is a clinical trial that was terminated before completion, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 1,278 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00013845 was terminated before completion, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

TERMINATED
Registry status
1,278 participants
Enrollment target

Study Summary

This protocol has three purposes: 1) to screen patients with seizures for participation in research studies of NINDS s Clinical Epilepsy Section (CES), 2) to follow the natural course of seizure disorders, and 3) to train CES fellows in evaluating and treating epilepsy. Only standard diagnostic tests and treatments will be used in this study. Patients of any age with seizures who are referred to CES may participate in this study. At the end of the study, patients may be discharged to the care of their referring physician, offered participation in another NINDS research protocol, or followed for teaching purposes. Participants will undergo standard diagnostic procedures used to determine the type of their seizures, what part of the brain they are coming from, what is causing them, and whether standard drug treatments can help them. These may include some or all of the following: * Physical and neurological examination * Neuropsychological tests tests of learning and memory * Electroencephalography (EEG) brain wave recording * Evoked potentials tests of nerve reactions to lights and sounds * Polysomnography simultaneous recordings of brain waves, breathing and eye movements * Video-EEG monitoring simultaneous recording of seizures using a video camera and brain waves * Video-EEG monitoring with extra electrodes to record muscle activity, breathing and eye movements for analyzing sleep patterns * Imaging studies, such as magnetic resonance imaging (MRI) and positron emission tomography (PET) scans to examine the structure and function of the brain * Frequent blood tests to measure blood levels of anti-seizure drugs

Trial Details

FieldValue
Enrollment Target 1,278 participants
Start Date 2001-05-01
Est. Completion 2018-06-26

What the Registry Record Tells You About NCT00013845

The ClinicalTrials.gov registry entry for NCT00013845 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,278 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00013845 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00013845 about?

NCT00013845 is a clinical study titled "Evaluation and Treatment of Patients With Epilepsy". This protocol has three purposes: 1) to screen patients with seizures for participation in research studies of NINDS s Clinical Epilepsy Section (CES), 2) to follow the natural course of seizure disorders, and 3) to train CES fellows in evaluating and treating epilepsy. Only standard diagnostic test...

What is the current status of trial NCT00013845?

This trial is currently terminated. The enrollment target is 1,278 participants. The study started on 2001-05-01. Estimated completion is 2018-06-26.

Who is sponsoring clinical trial NCT00013845?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.